Overview: Designed experiential branding for the launch of Lebrikizumab, supporting Eli Lilly’s introduction of a new treatment for atopic dermatitis. The experience balanced scientific authority with emotional clarity in a live, high-stakes environment.
Deliverables & Goals: Created event guidelines, presentation templates, environmental graphics, and branded materials to support education and engagement. The goal was to communicate trust, credibility, and care simultaneously.
Approach: Focused on translating complex medical information into clear, respectful, and human-centered design. Every element reinforced confidence without feeling cold or clinical.
Results: The cohesive experience supported strong engagement and reinforced confidence in the product launch. The brand presence felt both credible and empathetic.
